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ABSTRACT—Non-linear analysis of the electroencephalogram (EEG) background activity can 
help to obtain a better understanding of abnormal dynamics in the brain. The aim of this study was 
to analyze the regularity of the EEG time series of Alzheimer’s disease (AD) patients to test the 
hypothesis that the irregularity of the AD patients’ EEG is lower than that of age-matched controls. 
We recorded the EEG from 19 scalp electrodes in 11 AD patients and 11 age-matched controls and 
estimated the Approximate Entropy (ApEn). ApEn is a non-linear method that can be used to 
quantify the irregularity of a time series. Larger values correspond to more irregularity. We 
evaluated different values for input parameters m and r to estimate ApEn and concluded that m=1 
and r=0.25 times the SD of the time series were the optimum choices. With these parameters, ApEn 
was significantly lower in the AD patients at the P3, P4, O1 and O2 (p<0.01) electrodes. The 
decreased irregularity found in the EEG of AD patients in the parietal and occipital regions leads us 
to think that regularity analysis of the EEG with ApEn could be a useful tool to increase our insight 
into brain dysfunction in Alzheimer’s disease. 
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1.  INTRODUCTION 
Alzheimer’s disease (AD) is a primary degenerative dementia of unknown etiology that gradually 
destroys brain cells and represents the most prevalent form of dementia in western countries [1]. Clinically, 
AD manifests as a slowly progressive impairment of mental functions whose course lasts several years prior 
to the death of the patient [2]. Structural changes in AD are related to the accumulation of amyloid plaques 
between nerve cells in the brain and with the appearance of neurofibrillary tangles inside nerve cells, 
particularly in the hippocampus and the cerebral cortex [3]. Although a definite diagnosis is only possible 
by necropsy, a differential diagnosis with other types of dementia and with major depression should be 
attempted. Magnetic resonance imaging and computerized tomography can be normal in the early stages of 
AD but a diffuse cortical atrophy is the main sign in brain scans. Mental status tests are also useful. 
The electroencephalogram (EEG) has been used as a tool for investigating dementias for several 
decades. AD patients’ EEGs show a shift of the power spectrum to lower frequencies and a decrease of 
coherence among cortical areas [2]. However, in the early stages of the disease the EEG may exhibit normal 
frequencies and be similar to that of elderly control subjects [4]. 
Recent progress in the theory of non-linear dynamics has provided new methods for the study of the 
EEG [2]. Non-linearity is present in many dynamical systems found in nature. For a neuronal network such 
as the brain, non-linearity is introduced even at the cellular level, since the dynamical behavior of individual 
neurons is governed by threshold and saturation phenomena. Moreover, the hypothesis of an entirely 
stochastic brain can be rejected due to its ability to perform sophisticated cognitive tasks. For these reasons, 
the EEG appears to be an appropriate area for non-linear time series analysis [5]. Besides the aim of finding 
a certain dynamical model for the EEG, non-linear studies of the brain have proven to be very useful in 
making relative comparisons of different physiological states [6]–[8]. Many investigations with non-linear 
methods have revealed possible medical applications for non-linear analysis. 
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In particular, several authors have analyzed the EEG in AD patients with non-linear methods. It has 
been shown that AD patients have lower correlation dimension (D2) values – a measure of the underlying 
system dimensional complexity – than control subjects [9]–[11]. Furthermore, AD patients also have 
significantly lower values of the largest Lyapunov (L1) exponent than controls in almost all EEG channels 
[9]. However, estimating the non-linear dynamical complexity of physiological data using measures such as 
D2 and L1 is problematic, as the amount of data required for meaningful results in their computation is 
beyond the experimental possibilities for physiological data [12]. Furthermore, the algorithms to estimate 
the aforementioned non-linear metrics assume the time series to be stationary and this is generally not true 
with biological data. Thus, the study of the EEG background activity with more suitable non-linear methods 
becomes necessary. For instance, mutual information analysis [13] and synchronization likelihood [14], 
[15] have been used to assess information transmission between different cortical areas in AD. 
One alternative solution lies in computing the entropy of the EEG. Entropy is a concept addressing 
randomness and predictability, with greater entropy often associated with more randomness and less system 
order. Kolmogorov-Sinai entropy (K-S entropy), developed by Kolmogorov and expanded upon by Sinai, 
allows classifying deterministic dynamical systems by rate of information generation [16]. Unfortunately, 
K-S entropy was not developed for statistical applications and its blind application to practical time series 
will only evaluate system noise, not underlying system properties, as it generally requires a vast amount of 
input data to achieve convergence [17]. 
Approximate Entropy (ApEn) is a recently introduced family of statistics that quantifies regularity in 
the data without any a priori knowledge about the system generating them [18]. It was defined by Pincus 
[19], motivated by applications to short and noisy data sets (it is applicable to systems with at least 50 data 
points), along with thematically similar lines to K-S entropy. However, the focus was different: to provide a 
widely applicable, statistically valid formula that will distinguish data sets by a measure of regularity [19]. 
The present study was undertaken to examine the EEG background activity in AD with ApEn. We 
wanted to test the hypothesis that the irregularity of the AD patients’ EEG is lower than that of age-matched 
controls, hence indicating an abnormal type of dynamics in this group. 
2.  MATERIAL AND METHODS 
2.1  Subjects 
Twenty-two subjects participated in this study. Informed consent was obtained from all control subjects 
and all caregivers of the demented patients. The study was approved by the local ethics committee. 
Eleven patients (5 men and 6 women; age = 72.5 ± 8.3 years, mean ± standard deviation SD) fulfilling 
the criteria of probable AD were recruited from the Alzheimer’s Patients’ Relatives Association of 
Valladolid (AFAVA) and referred to the University Hospital of Valladolid (Spain), where EEGs were 
recorded. The diagnosis was made on the basis of exhaustive medical, physical, neurological, psychiatric 
and neuropsychological examinations. Mini-Mental State Examination (MMSE) was used to assess the 
cognitive function [20]. The mean MMSE score for the patients was 13.1 ± 5.9 (Mean ± SD). Five of them 
had a score of less than 12 points, indicating a severe degree of dementia. Two patients were receiving 
lorapezam. Although with therapeutic doses, benzodiapzepines may enhance beta activity, no prominent 
rapid rhythms were observed in the visual examination of their EEGs. None of the other patients used 
medication that could be expected to influence the EEG. 
The control group consisted of 11 age-matched, elderly control subjects without past or present 
neurological disorders (7 men and 4 women; age = 72.8 ± 6.1 years, mean ± SD). The MMSE score value 
was 30 in all control subjects. 
2.2  EEG recording 
EEGs were recorded from the 19 scalp loci of the international 10-20 system (electrodes F3, F4, F7, 
F8, Fp1, Fp2, T3, T4, T5, T6, C3, C4, P3, P4, O1, O2, Fz, Cz and Pz) using a Profile Study Room 2.3.411 
EEG equipment (Oxford Instruments). More than five minutes of data were recorded from each subject. 
The sample frequency was 256 Hz, with a 12-bit A-to-D precision. Recordings were made with the subjects 
in a relaxed state and under the eyes-closed condition in order to obtain as many artifact-free EEG data as 
possible. 
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All EEGs were visually inspected by a specialist physician to check for eye movement and other 
artifacts. Only EEG data free from electrooculographic and movement artifacts and with minimal 
electromyographic (EMG) activity were selected for non-linear analysis. EEGs were then organized in 5 
second epochs (1280 points). An average number of 30.0 ± 12.5 artifact-free epochs (Mean ± SD) were 
selected from each electrode for each subject and copied as ASCII files for off-line analysis on a personal 
computer. Furthermore, prior to the ApEn estimation, all recordings were digitally filtered with a band-pass 
filter with cut-off frequencies at 0.5 Hz and at 40 Hz in order to remove residual EMG activity. 
2.3  Approximate entropy 
ApEn was introduced as a quantification of regularity in sequences and time series, initially motivated 
by applications to relatively short, noisy data sets [19]. It provides a finite sequence formulation of 
randomness, via proximity to maximal irregularity [21], [22]. Moreover, ApEn is scale invariant and model 
independent, evaluates both dominant and subordinated patterns in data, and discriminates series for which 
clear feature recognition is difficult [23]. Notably, it detects changes in underlying episodic behavior not 
reflected in peak occurrences or amplitudes [24]. ApEn can be applied to discriminate both general classes 
of correlated stochastic processes, as well as noisy deterministic systems, and it is nearly unaffected by low 
level noise [23]. Furthermore, it is complementary to spectral and autocorrelation analyses, providing 
effective discriminatory capability in instances in which the aforementioned measures exhibit minimal 
distinctions [23], [25]. 
ApEn assigns a non-negative number to a time series, with larger values corresponding to more 
irregularity in the data. Two input parameters, a run length m and a tolerance window r, must be specified to 
compute ApEn. Briefly, ApEn measures the logarithmic likelihood that runs of patterns that are close 
(within r) for m contiguous observations remain close (within the same r) on subsequent incremental 
comparisons. It is important to consider ApEn(m, r, N), where N is the number of points of the time series, 
as a family of characterizing measures: comparisons between time series can only be made with the same 
values of m, r and N [23]. Given N data points from a time series {x(n)} = x(1), x(2), …,x(N), one should 
follow these steps to compute ApEn [23]: 
1. Form N-m+1 vectors X(1)…X(N-m+1) defined by: X(i) = [x(i), x(i+1),…, x(i+m-1)], i = 1…N-m+1. 
2. Define the distance between X(i) and X(j), d[X(i),X(j)], as the maximum norm: 
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5. Increase the dimension to m+1. Repeat steps 1) to 4) and find )(1 iCmr +  and )(1 rm+φ . 
6. We define ApEn by: 
 )()(),,( 1 rrNrmApEn mm +−= φφ  (4) 
Although m and r are critical in determining the outcome of ApEn, no guidelines exist for optimizing 
their values. In principle, the accuracy and confidence of the entropy estimate improve as the number of 
matches of length m and m + 1 increases. This condition can be fulfilled by choosing small m (short 
templates) and large r (wide tolerance). However, there are penalties for criteria that are too relaxed [19]. 
For smaller r values, one usually achieves poor conditional probability estimates, while for larger r values, 
4 Intelligent Automation and Soft Computing 
too much detailed system information is lost. To avoid a significant contribution of noise in an ApEn 
calculation, one must choose r larger than most of the noise [19]. It has been suggested to estimate ApEn 
with parameter values of m=1, m=2 and r=0.1, 0.15, 0.2 and 0.25 times the standard deviation (SD) of the 
original data sequence {x(n)} [23]. Normalizing r in this manner gives ApEn a translation and scale 
invariance, in that it remains unchanged under uniform process magnification, reduction, or constant shift to 
higher or lower values [23]. Moreover, it has been demonstrated that these input parameters produce good 
statistical reproducibility for ApEn for time series of length N≥60, as considered herein [19], [24]. ApEn 
was calculated with a short computer program written in MATLAB®. 
2.4  Statistical analysis 
Student’s t-test was used to evaluate the statistical differences between the ApEn values for AD patients 
and control subjects. Differences were considered statistically significant if the p value was lower than 0.01. 
The ability to discriminate AD patients from control subjects at the electrodes where p < 0.01 was 
evaluated using Receiver Operating Characteristic (ROC) curves [26]. We define sensitivity as the rate of 
patients with a diagnosis of AD who test positive (i.e. the true positive rate), whereas specificity represents 
the fraction of controls correctly recognized (i.e. the true negative rate). We used a computer program 
developed with MATLAB® that automatically selected different cut-off points (ApEn values) and calculated 
the sensitivity/specificity pair for each one of them. Accuracy is a related parameter that quantifies the total 
number of subjects (AD patients and control subjects) precisely classified. Using these curves, we selected 
an optimum threshold as the cut-off point in which the highest accuracy (minimal false negative and false 
positive results) was obtained. It was determined graphically from the ROC curve as the closest value to the 
left top point (100% sensitivity, 100% specificity). 
3.  RESULTS 
ApEn was estimated at channels Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4, T5 and T6 
with m = 1, m = 2 and r a fixed value between 0.1 and 0.25 times the SD of the original data sequence. 
Results were averaged based on all the artifact-free 5 second epochs within the five-minute period of EEG 
recordings. The average ApEn values for both groups and the p-values of the Student’s t-test performed to 
examine the differences between them for the 16 analyzed electrodes are summarized in Table I (m=1) and 
Table II (m=2). 
With m=1 and all different combinations of r values (0.1, 0.15, 0.2 and 0.25 times the SD of the 
analyzed epoch) significant differences between both groups were found at electrodes P3, P4, O1 and O2. 
However, that was not the case with m=2. With that run length and r=0.2 times the SD, significant 
differences between both groups were only found at electrode P3. Results improved with m=2 and r=0.25 
times the SD, as significant differences were found at electrodes P3, P4 and O1. These results suggest that 
the choice of m and r is critical to find the subtle differences that might exist between the EEG background 
activity in AD patients and control subjects. 
Finally, we evaluated the ability of ApEn to discriminate AD patients from control subjects at the 
electrodes in which significant differences were found using ROC plots. Our objective was to determine the 
optimum threshold (ApEn value) that maximized the diagnostic accuracy. As an example, Figure 1 
represents the ROC curves corresponding to ApEn(m=1, r=0.25 times the SD) at electrodes P3, P4, O1 and 
O2. When ApEn was estimated with m=1 the accuracy was 77.27% at electrodes P3, O1 and O2 and 
72.73% at P4. Sensitivities varied between 90.91% at electrode O2 for all possible combinations of r and m 
fixed to 1 and 63.64% at P4 when m=1 and r=0.25 times the SD of the time series. However, it must be 
noted that an excellent sensitivity at O2 had a low specificity associated. Specificities ranged between 
63.64% at electrode O2 and 81.82% at P3. When ApEn was estimated with m=2 and r=0.25 times the SD of 
the data, we obtained an accuracy of 81.82% at electrode P3, with a specificity of 100%, meaning that all 
control subjects could be correctly classified by the method. Table III summarizes these results. 
Furthermore, it also includes the ApEn value that maximizes the accuracy obtained with the ROC curves 
and the area under the ROC curve (AROC). The AROC curve can be used to classify the precision of a 
diagnostic test. An AROC of 0.8595 means that a randomly selected individual from the control subjects’ 
group has an ApEn value larger than that of a randomly chosen individual from the AD patients’ group in 
85.95% of the time [26]. Usually, larger AROCs are associated with better diagnostic tests. Hence, 
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according to the AROC, the best results are those obtained with m=1 at electrodes P3 and O1 
(AROC=0.8595). 
 
4.  DISCUSSION AND CONCLUSIONS 
The diagnosis of AD, the main cause of dementia in western countries, is becoming an increasingly 
important problem for clinical medicine as new therapies emerge. In this pilot study we analyzed the EEG 
background activity of 11 control subjects and 11 AD patients with ApEn, a family of statistics that 
Table I 
Average ApEn values with m=1. Significant differences (p < 0.01) are marked with an asterisk. 
r=0.1 times the SD r=0.15 times the SD 
E AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) p-value E 
AD patients 
(Mean ± SD) 
Control subjects 
(Mean ± SD) p-value 
F3 1.3663 ± 0.1642 1.4995 ± 0.2142 0.1172 F3 1.0250 ± 0.1547 1.1558 ± 0.2131  0.1150 
F4 1.4452 ± 0.1816 1.4666 ± 0.2481 0.8198 F4 1.1031 ± 0.2010 1.1215 ± 0.2451 0.8489 
F7 1.4884 ± 0.1928 1.5381 ± 0.2503 0.6078 F7 1.1477 ± 0.1900 1.1941 ± 0.2468 0.6271 
F8 1.4892 ± 0.1887 1.5623 ± 0.2143 0.4055 F8 1.1453 ± 0.1860 1.2154 ± 0.2118 0.4193 
Fp1 1.2374 ± 0.3395 1.4781 ± 0.1902 0.0536 Fp1 0.9202 ± 0.2908 1.1328 ± 0.1902 0.0559 
Fp2 1.2820 ± 0.1970 1.4490 ± 0.2623 0.1068 Fp2 0.9486 ± 0.1828 1.1063 ± 0.2590 0.1144 
T3 1.7017 ± 0.2676 1.7323 ± 0.3411 0.8169 T3 1.3601 ± 0.2718 1.3935 ± 0.3354 0.8006 
T4 1.7041 ± 0.3399 1.7108 ± 0.2821 0.9604 T4 1.3653 ± 0.3464 1.3683 ± 0.2839 0.9823 
T5 1.4430 ± 0.2617 1.6979 ± 0.2120 0.0207 T5 1.1004 ± 0.2549 1.3546 ± 0.2140 0.0198 
T6 1.4345 ± 0.2733 1.6829 ± 0.2292 0.0316 T6 1.0934 ± 0.2660 1.3379 ± 0.2300 0.0319 
C3 1.4771 ± 0.2476 1.6197 ± 0.1790 0.1373 C3 1.1375 ± 0.2394 1.2731 ± 0.1841 0.1521 
C4 1.5271 ± 0.2503 1.6347 ± 0.1446 0.2313 C4 1.1867 ± 0.2469 1.2882 ± 0.1491 0.2568 
P3* 1.3303 ± 0.2502 1.6488 ± 0.1380 0.0014 P3* 0.9938 ± 0.2364 1.3020 ± 0.1423 0.0014 
P4* 1.3802 ± 0.2364 1.6540 ± 0.1403 0.0036 P4* 1.0390 ± 0.2255 1.3068 ± 0.1439 0.0034 
O1* 1.4543 ± 0.2283 1.7661 ± 0.1841 0.0021 O1* 1.1100 ± 0.2268 1.4219 ± 0.1906 0.0023 
O2* 1.4382 ± 0.2345 1.7247 ± 0.2189 0.0077 O2* 1.0939 ± 0.2318 1.3804 ± 0.2233 0.0079 
r=0.2 times the SD r=0.25 times the SD 
E AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) p-value E 
AD patients 
(Mean ± SD) 
Control subjects 
(Mean ± SD) p-value 
F3 0.7921 ± 0.1374 0.9136 ± 0.2002 0.1128 F3 0.6288 ± 0.1181 0.7378 ± 0.1821 0.1115 
F4 0.8643 ± 0.1572 0.8819 ± 0.2268 0.8349 F4 0.6933 ± 0.1371 0.7100 ± 0.2028 0.8242 
F7 0.9086 ± 0.1789 0.9507 ± 0.2299 0.6374 F7 0.7349 ± 0.1634 0.7732 ± 0.2072 0.6355 
F8 0.9047 ± 0.1733 0.9682 ± 0.1975 0.4323 F8 0.7309 ± 0.1563 0.7867 ± 0.1775 0.4426 
Fp1 0.7101 ± 0.2423 0.8915 ± 0.1803 0.0602 Fp1 0.5641 ± 0.2006 0.7182 ± 0.1649 0.0631 
Fp2 0.7274 ± 0.1602 0.8688 ± 0.2423 0.1220 Fp2 0.5745 ± 0.1363 0.6994 ± 0.2194 0.1243 
T3 1.1110 ± 0.2627 1.1462 ± 0.3142 0.7788 T3 0.9236 ± 0.2472 0.9580 ± 0.2869 0.7663 
T4 1.1189 ± 0.3359 1.1181 ± 0.2702 0.9950 T4 0.9342 ± 0.3186 0.9296 ± 0.2485 0.9701 
T5 0.8633 ± 0.2346 1.1028 ± 0.2073 0.0196 T5 0.6936 ± 0.2081 0.9125 ± 0.1953 0.0193 
T6 0.8586 ± 0.2444 1.0869 ± 0.2190 0.0318 T6 0.6914 ± 0.2179 0.8976 ± 0.2018 0.0322 
C3 0.9002 ± 0.2186 1.0227 ± 0.1786 0.1658 C3 0.7291 ± 0.1954 0.8363 ± 0.1670 0.1820 
C4 0.9457 ± 0.2329 1.0371 ± 0.1462 0.2833 C4 0.7703 ± 0.2150 0.8490 ± 0.1384 0.3198 
P3* 0.7672 ± 0.2104 1.0497 ± 0.1397 0.0014 P3* 0.6088 ± 0.1817 0.8599 ± 0.1331 0.0014 
P4* 0.8063 ± 0.2023 1.0547 ± 0.1402 0.0032 P4* 0.6423 ± 0.1753 0.8644 ± 0.1320 0.0031 
O1* 0.8706 ± 0.2131 1.1666 ± 0.1876 0.0025 O1* 0.6989 ± 0.1939 0.9714 ± 0.1801 0.0027 
O2* 0.8560 ± 0.2163 1.1277 ± 0.2173 0.0081 O2* 0.6867 ± 0.1961 0.9357 ± 0.2051 0.0086 
E: Electrode; SD: Standard deviation 
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evaluates the regularity in time series, with larger values corresponding to more irregularity in the data. We 
have found that AD patients have lower ApEn values than control subjects at nearly all electrodes for all the 
studied combinations of m and r, with the exception of T3 and T4, where the mean ApEn values are 
sometimes slightly higher in AD patients. Furthermore, this study proves that the choice of m and r is 
critical to find significant differences. Our results show that estimating ApEn with m=1 allows us to detect 
more regularity differences between the EEG of AD patients and control subjects, irrespective of the r 
value, than m=2, where only relatively large r values are useful. Thus, it seems that choosing m=1 is 
necessary to discriminate series for which clear feature recognition is difficult and to detect subtle 
Table II 
Average ApEn values with m=2. Significant differences (p < 0.01) are marked with an asterisk. 
r=0.1 times the SD r=0.15 times the SD 
E AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) p-value E 
AD patients 
(Mean ± SD) 
Control subjects 
(Mean ± SD) p-value 
F3 0.8281 ± 0.0474 0.8863 ± 0.1032 0.1045 F3 0.7094 ± 0.0426 0.7628 ± 0.0890 0.0879 
F4 0.8577 ± 0.0937 0.8797 ± 0.0925 0.5862 F4 0.7395 ± 0.0748 0.7534 ± 0.0796 0.6774 
F7 0.9164 ± 0.1169 0.9169 ± 0.1197 0.9930 F7 0.7887 ± 0.1046 0.7938 ± 0.1078 0.9104 
F8 0.9110 ± 0.1242 0.9360 ± 0.1158 0.6305 F8 0.7882 ± 0.1068 0.8060 ± 0.1044 0.6972 
Fp1 0.7963 ± 0.1464 0.8969 ± 0.1057 0.0796 Fp1 0.6702 ± 0.1412 0.7717 ± 0.0902 0.0581 
Fp2 0.8227 ± 0.0722 0.8872 ± 0.1310 0.1681 Fp2 0.6959 ± 0.0663 0.7645 ± 0.1206 0.1143 
T3 1.0065 ± 0.1355 1.0003 ± 0.1590 0.9230 T3 0.8872 ± 0.1341 0.8840 ± 0.1610 0.9606 
T4 0.9989 ± 0.1337 0.9999 ± 0.1375 0.9872 T4 0.8820 ± 0.1502 0.8743 ± 0.1282 0.8990 
T5 0.8632 ± 0.1263 0.9341 ± 0.1357 0.2191 T5 0.7463 ± 0.1046 0.8206 ± 0.1238 0.1439 
T6 0.8560 ± 0.1308 0.9491 ± 0.1395 0.1217 T6 0.7445 ± 0.1152 0.8300 ± 0.1169 0.0992 
C3 0.8633 ± 0.1222 0.9143 ± 0.0685 0.2411 C3 0.7491 ± 0.1099 0.7900 ± 0.0599 0.2909 
C4 0.8836 ± 0.1238 0.9126 ± 0.0735 0.5124 C4 0.7679 ± 0.1225 0.7888 ± 0.0572 0.6127 
P3 0.7824 ± 0.1032 0.8921 ± 0.1013 0.0205 P3 0.6827 ± 0.0827 0.7783 ± 0.0748 0.0101 
P4 0.7913 ± 0.0878 0.8840 ± 0.1207 0.0528 P4 0.6949 ± 0.0714 0.7771 ± 0.0897 0.0273 
O1 0.8559 ± 0.1040 0.9683 ± 0.1426 0.0476 O1 0.7431 ± 0.0921 0.8558 ± 0.1308 0.0299 
O2 0.8484 ± 0.1084 0.9682 ± 0.1476 0.0423 O2 0.7374 ± 0.0954 0.8530 ± 0.1328 0.0294 
r=0.2 times the SD r=0.25 times the SD 
E AD patients (Mean ± SD) 
Control subjects 
(Mean ± SD) p-value E 
AD patients 
(Mean ± SD) 
Control subjects 
(Mean ± SD) p-value 
F3 0.6289 ± 0.0484 0.6756 ± 0.0736 0.0935 F3 0.5645 ± 0.0573 0.6105 ± 0.0700 0.1070 
F4 0.6570 ± 0.0632 0.6654 ± 0.0742 0.7765 F4 0.5931 ± 0.0641 0.5973 ± 0.0788 0.8909 
F7 0.6923 ± 0.0856 0.7001 ± 0.0920 0.8398 F7 0.6190 ± 0.0765 0.6285 ± 0.0875 0.7902 
F8 0.6937 ± 0.0833 0.7101 ± 0.0861 0.6548 F8 0.6198 ± 0.0728 0.6389 ± 0.0792 0.5640 
Fp1 0.5810 ± 0.1396 0.6798 ± 0.0713 0.0497 Fp1 0.5124 ± 0.1385 0.6091 ± 0.0641 0.0486 
Fp2 0.6068 ± 0.0687 0.6721 ± 0.1021 0.0937 Fp2 0.5361 ± 0.0740 0.5994 ± 0.0953 0.0974 
T3 0.7770 ± 0.1120 0.7746 ± 0.1397 0.9648 T3 0.6936 ± 0.0958 0.6930 ± 0.1280 0.9890 
T4 0.7732 ± 0.1289 0.7662 ± 0.1065 0.8909 T4 0.6891 ± 0.1123 0.6860 ± 0.0964 0.9466 
T5 0.6617 ± 0.0896 0.7325 ± 0.0937 0.0852 T5 0.5948 ± 0.0900 0.6690 ± 0.0743 0.0478 
T6 0.6587 ± 0.0997 0.7361 ± 0.0910 0.0718 T6 0.5904 ± 0.0975 0.6682 ± 0.0787 0.0526 
C3 0.6650 ± 0.0952 0.7035 ± 0.0480 0.2453 C3 0.5998 ± 0.0903 0.6411 ± 0.0452 0.1898 
C4 0.6819 ± 0.1036 0.7040 ± 0.0402 0.5178 C4 0.6161 ± 0.0920 0.6439 ± 0.0333 0.3580 
P3* 0.6110 ± 0.0784 0.7015 ± 0.0491 0.0041 P3* 0.5498 ± 0.0850 0.6461 ± 0.0360 0.0025 
P4 0.6247 ± 0.0699 0.7021 ± 0.0610 0.0119 P4* 0.5657 ± 0.0785 0.6475 ± 0.0455 0.0072 
O1 0.6623 ± 0.0769 0.7619 ± 0.0982 0.0155 O1* 0.5977 ± 0.0743 0.6939 ± 0.0744 0.0066 
O2 0.6568 ± 0.0803 0.7561 ± 0.1011 0.0190 O2 0.5921 ± 0.0785 0.6853 ± 0.0815 0.0129 
E: Electrode; SD: Standard deviation 
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differences in the EEG background activity. To avoid a significant contribution of noise in an ApEn 
calculation, one must choose r larger than most of the noise [19]. Thus, despite that for m=1 all considered r 
values provided similar results, r=0.25 times the SD of the time series is the best option among them. 
Considering the results from this study, we infer that brains affected by AD show a more regular 
electrophysiological behavior, especially in the parietal and occipital regions. 
Our results agree with other studies that have shown differences between the EEG background activity 
of AD patients and control subjects with non-linear analysis techniques. AD patients’ EEGs have lower D2 
values than EEGs of control subjects [9–11], [27]. Consequently, AD patients are characterized by a less 
complex brain activity. Furthermore, it has been shown that AD patients have significantly lower L1 values 
than age-matched controls [9], [10]. Given the fact that the L1 of the EEG can be interpreted as a measure 
of flexibility of information processing in the brain [28], decreased L1 values in AD patients reflect a drop 
in the flexibility of information processing in the injured brain [2]. The decreased complexity of brain 
activity in AD patients has also been shown using Lempel-Ziv complexity [29]. 
We evaluated the ability of ApEn to discriminate AD patients from control subjects at the electrodes 
where significant differences were found using ROC curves. We obtained accuracies between 72.73% and 
81.82%. Other studies have reported good accuracies when classifying AD patients and control subjects 
with non-linear techniques. For instance, D2 correctly classified AD patients and controls with an accuracy 
of 70% [30]. Moreover, the addition of D2 and a neural net classification procedure to linear methods 
improves the classification accuracy of AD up to 92% [11]. Furthermore, with a similar set of patients to the 
one considered in this study, we obtained accuracies between 77.27% and 90.91% with other non-linear 
methods, like Lempel-Ziv complexity [29], sample entropy [31] or multiscale entropy [32]. 
Parameters such as D2, K-S entropy, L1 and related algorithms have been much studied in the presence 
of noise and limited data. Most of these methods successfully use dimensions larger than m=1 or m=2, as is 
typical with ApEn. Thus, in the purely deterministic dynamical system for which these methods were 
developed, they reconstruct the probability structure of the space with greater detail than ApEn does. 
  (a) (b) 
  (c) (d) 
Figure 1. ROC curves for ApEn(m=1, r=0.25 times the SD) at the electrodes where p < 0.01. (a) P3. 
(b) P4. (c) O1. (d) O2. 
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However, in the general stochastic, noisy deterministic or composite setting, the statistical accuracy of the 
aforementioned parameters and methods is typically very poor [19], [21]. Because dynamics of most 
biological signals remain undefined, a suitable statistic of regularity for these signals must be more cautious 
to accommodate general classes of processes and their much more diffuse reconstructed dynamics [23]. In 
fact, several properties of ApEn facilitate its utility for empirical time series analysis of the sort of EEGs 
[23]: (i) ApEn is nearly unaffected by noise below a de facto specified filter level (r), (ii) ApEn can be 
applied to time series of 50 or more points with good reproducibility, (iii) ApEn is finite for stochastic, 
noisy deterministic and composite processes, and (iv) increasing values of ApEn correspond to more 
irregularity in the time series. Moreover, when applied to the analysis of biomedical time series, ApEn does 
not show the important drawbacks that many widely applied non-linear methods (D2, L1, etc.) have. 
ApEn reflects the rate of new pattern generation when the dimension decreases from m+1 to m. A larger 
value of ApEn means that the chance of new pattern generation is greater, so the sequence is more irregular. 
Given that EEG patterns reflect cortical activity (information processing) of the brain, the reduced ApEn in 
AD patients’ EEG suggests deficient information processing of the cortex due to the inactivation of 
previously active networks [2]. Our findings are compatible with the more general hypothesis that a loss of 
complexity appears when biological systems become functionally impaired [33]. The EEG irregularity 
reduction found in some regions could be explained by a decrease of dynamical complexity of part of the 
brain. However, the pathophysiological implications of this decreased irregularity are not clear. Among 
others, three mechanisms can be responsible for it: neuronal death, a general effect of neurotransmitter 
deficiency and loss of connectivity of local neural networks as a result of nerve cell death [2]. 
Some limitations of our study merit consideration. First of all, the sample size was small and, as a 
result, our findings are preliminary. Hence, to prove the usefulness of ApEn as a diagnostic tool, this 
approach should be extended on a much larger patient population. Moreover, the EEG changes detected 
with non-linear analysis techniques are not specific to AD. Among others, they have been found in several 
pathological states, including vascular dementia [9], Parkinson’s disease [27], schizophrenia [28], epilepsy 
[34] and the Creutzfeld-Jakob disease [35]. Thus, although this study shows that ApEn might be a helpful 
Table III 
ApEn test results on the channels where significant differences (p < 0.01) between both groups 
were found. The optimum thresholds to discriminate AD patients and control subjects and the 
area under the ROC curves are included. 
m and r 
values Electrode Threshold 
Sensitivity 
(%) 
Specificity 
(%) 
Accuracy 
(%) AROC 
m=1, r=0.1 
P3 1.5163 72.73 81.82 77.27 0.8595 
P4 1.5323 72.73 72.73 72.73 0.8347 
O1 1.5885 81.82 72.73 77.27 0.8595 
O2 1.6113 90.91 63.64 77.27 0.7769 
m=1, r=0.15 
P3 1.1661 72.73 81.82 77.27 0.8595 
P4 1.1849 72.73 72.73 72.73 0.8347 
O1 1.2460 81.82 72.73 77.27 0.8595 
O2 1.2621 90.91 63.64 77.27 0.7769 
m=1, r=0.2 
P3 0.9157 72.73 81.82 77.27 0.8595 
P4 0.9413 72.73 72.73 72.73 0.8347 
O1 0.9999 81.82 72.73 77.27 0.8595 
O2 1.0080 90.91 63.64 77.27 0.7769 
m=1, r=0.25 
P3 0.7326 72.73 81.82 77.27 0.8595 
P4 0.7381 63.64 81.82 72.73 0.8264 
O1 0.8181 81.82 72.73 77.27 0.8595 
O2 0.8190 90.91 63.64 77.27 0.7769 
m=2, r=0.2 P3 0.6519 63.64 90.91 77.27 0.8017 
m=2, r=0.25 
P3 0.6081 63.64 100 81.82 0.8264 
P4 0.6166 81.82 72.73 77.27 0.8347 
O1 0.6219 63.64 90.91 77.27 0.8347 
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tool for recognition of AD, further work must be carried out to examine non-linear EEG activity in other 
types of dementia. 
In summary, although non-linear EEG analysis cannot yet be applied as a diagnostic tool, our findings 
show the possibility to analyze the dynamical behavior of the brain in AD patients and to detect significant 
differences with ApEn. Furthermore, this study shows which combination of parameters m and r is more 
suitable to analyze the EEG background activity in AD. Our experimental results prove the potential 
applications of this new family of statistics to EEG background activity characterization in AD. The EEG 
entropy decrease in the parietal and occipital regions in AD patients leads us to think that EEG analysis with 
ApEn could be a useful tool to increase our insight into brain dysfunction in this disease. 
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